It consists of 41 items assessing the core psychopathology of eating disorders across four subscales (Restraint, Eating Concern, Shape Concern, and Weight Concern)
It should not be used concurrently with other GLP-1 receptor agonists
It could also reflect dose-dependent effects on muscle metabolism that are not fully understood
Dulaglutide (Trulicity): Once-weekly subcutaneous injection licensed for type 2 diabetes management Liraglutide (Victoza, Saxenda): Daily subcutaneous injection
Cohorts were balanced on covariates, including demographics, medications, diagnoses, and procedures, using propensity score matching (PSM)
Addressing specific nutritional deficiencies requires a multidisciplinary approach